http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2009000733-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bd4e87ecbca17f16d460ca394e60f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-10
filingDate 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbd9e08028f2daa37af81ae6788a633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca51706edcb55a1987e4e6cd1b8aa9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd4c22b28d3ec55c90d032699c280f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1901d8858bd75844955de64dc206fd6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2823fade7ad735e43b327d70f86f06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1f1e4eadf9458ac569224134364b3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e1d41cf2733b06aab602ee41baa06bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0cfc35549d26821de7e8337b007caba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7941c50d4bc4d95ce481ebcd4d8d7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a930e07fc104b39eddc41ee45d8b49
publicationDate 2009-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2009000733-A1
titleOfInvention Compounds derived from (hetero) aryl-substituted cyclohexane, pharmaceutical composition containing said compound and its use as modulators of the ยต-opioid receptor and the orl-1 receptor to treat pain, anxiety, depression, epilepsy, Alzheimer's, senile dementia, withdrawal symptoms, alcohol abuse.
abstract COMPOUNDS OF GENERAL FORMULA 1, WHERE R1, R2, R3, Y1, Y1 ', Y2, Y2', Y3, Y3 ', Y4, Y4', AND Q ARE AS DEFINED IN THE SPECIFICATIONS OF CLAIMS THAT HAVE AFFINITY WITH THE RECEIVER OF OPLOIDES IJ AND WITH THE RECEIVER ORL-1; PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS IN THE FORM OF AN INDIVIDUAL STEREOISOMER OR A MIXTURE OF SEVERAL OF THE FREE COMPOUNDS AND / OR THEIR PHYSIOLOGICALLY COMPATIBLE SALTS AND / OR SOLVATES; AND ITS USE TO TREAT PAIN, ANXIETY, DEPRESSION, EPILEPSY, ALZHEIMER, SENILE DEMENTIA, WITHDRAWAL SYMPTOMS, ALCOHOL ABUSE ..
priorityDate 2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18389
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47748
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79292
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41146
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4987
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35370
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35377
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280

Total number of triples: 66.